Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Smits, Gaby ^a   Mollema, Liesbeth ^a   Hahné, Susan ^a   de Melker, Hester ^a   Tcherniaeva, Irina ^a   Waaijenborg, Sandra ^a   van Binnendijk, Rob ^a   van der Klis, Fiona ^a   Berbers, Guy ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUTCH; EPIDEMIC; ETHNIC GROUP; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; INFANT; INFECTION PREVENTION; MALE; MUMPS; MUMPS VIRUS; NETHERLANDS; POPULATION RESEARCH; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUMPS; MUMPS VACCINE; NETHERLANDS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 84874787460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058234     Document Type: Article

References (38)

1. Baum SG, Litman N (2000) Mumps virus. In: Mandell, Douglas, Bennet, editors. Principles and Practice of Infectious Diseases. 5th edition, volume 2. Oxford: Churchill Livingstone. 1708-1714.
2. Burgmeijer R, Hoppenbrouwers K, Bolscher N (2007) Handboek vaccinaties (theorie en uitvoeringspraktijk). 18 p.
3. Van Lier EA, Oomen PJ, Giesbers H, Drijfhout IH, de Hoogh PAAM,et al. (2012) Immunization coverage National Immunization Programme in the Netherlands. RIVM Rapport 201001001/2012.
4. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, et al. (2010) Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 28: 2932-2936.
5. Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, et al. (2011) Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill 16.
6. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, et al. (2010) Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 15.
7. Greenland K, Whelan J, Fanoy E, Borgert M, Hulshof K, et al. (2012) Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine 30: 4676-4680.
8. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, et al. (2008) Recent resurgence of mumps in the United States. N Engl J Med 358: 1580-1589.
9. Kay D, Roche M, Atkinson J, Lamden K, Vivancos R (2011) Mumps outbreaks in four universities in the North West of England: Prevention, detection and response. Vaccine.
10. De Melker HE, Conyn-van Spaendonck MA, (1998) Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 121: 637-643.
11. van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA, (2009) Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med 67: 301-308.
12. Smits GP, van Gageldonk PG, Schouls LM, van der Klis FR, Berbers GA (2012) Development of a bead-based multiplex immunoassay for the simultaneously quantitative detection of IgG serum antibodies against Measles, Mumps, Rubella and Varicella Zoster. Clin Vaccine Immunol.
13. Andrews N, Pebody RG, Berbers G, Blondeau C, Crovari P, et al. (2000) The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 125: 127-141.
14. van den Hof S, Beaumont MT, Berbers GA, de Melker HE, (2003) Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay. Epidemiol Infect 131: 703-709.
15. Wallinga J, Teunis P, Kretzschmar M, (2006) Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 164: 936-944.
16. Anderson RM, May RM, (1985) Vaccination and herd immunity to infectious diseases. Nature 318: 323-329.
17. Sandra Waaijenborg SH, Liesbeth Mollema, Gaby P. Smits, Guy A.M. Berbers, Fiona R.M. van der Klis, Hester E. de Melker, Jacco Wallinga (Under submission) Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.
18. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C, (2005) The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23: 4070-4074.
19. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, et al. (2007) Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13: 12-17.
20. Dominguez A, Torner N, Castilla J, Batalla J, Godoy P, et al. (2010) Mumps vaccine effectiveness in highly immunized populations. Vaccine 28: 3567-3570.
21. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H, (2008) Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 197: 950-956.
22. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, et al. (2008) Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 197: 1662-1668.
23. Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H, (2007) Long-term persistence of antibodies after one or two doses of MMR-vaccine. Vaccine 25: 6672-6676.
24. LeBaron CW, Forghani B, Beck C, Brown C, Bi D, et al. (2009) Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 199: 552-560.
25. Cook IF, (2008) Sexual dimorphism of humoral immunity with human vaccines. Vaccine 26: 3551-3555.
26. Mitchell LA, (1999) Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation. J Med Microbiol 48: 1075-1080.
27. Green MS, Shohat T, Lerman Y, Cohen D, Slepon R, et al. (1994) Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol 23: 1078-1081.
28. Jokinen S, Osterlund P, Julkunen I, Davidkin I, (2007) Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis 196: 861-867.
29. Vandermeulen C, Clement F, Roelants M, Van Damme P, Hoppenbrouwers K, et al. (2009) Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination. J Infect Dis 199: 1457-1460.
30. Dittrich S, Hahne S, van Lier A, Kohl R, Boot H, et al. (2011) Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine 29: 9271-9275.
31. Fanoy EB, Cremer J, Ferreira JA, Dittrich S, van Lier A, et al. (2011) Transmission of mumps virus from mumps-vaccinated individuals to close contacts. Vaccine 29: 9551-9556.
32. Plotkin SA, Ovenstein WA, Offit PA (2008) Vaccines. 5th Edition. 439 p.
33. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, et al. (2012) Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 86: 615-620.
34. Christenson B, Bottiger M, (1994) Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 12: 41-45.
35. Horstmann DM, Schluederberg A, Emmons JE, Evans BK, Randolph MF, et al. (1985) Persistence of vaccine-induced immune responses to rubella: comparison with natural infection. Rev Infect Dis 7Suppl 1: S80-85.
36. van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA, (1999) Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine 18: 931-940.
37. Mossong J, Putz L, Schneider F, (2004) Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 132: 11-18.
38. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, et al. (2008) Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill 13.